Published in Pain and Central Nervous System Week, September 29th, 2003
"Recent developments in stem-cell and gene therapy will require methods to monitor stem-cell survival and integration repeatedly and non-invasively with a high temporal and spatial resolution in vivo. The aim of this study was to visualize embryonic and neuronal stem cells with standard contrast agents using a conventional clinical 1.5-Tesla scanner," scientists in Germany reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.